These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28120452)

  • 1. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
    Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
    Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
    Tilley C; Deep G; Agarwal C; Wempe MF; Biedermann D; Valentová K; Kren V; Agarwal R
    Mol Carcinog; 2016 Jan; 55(1):3-14. PubMed ID: 25492239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
    Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
    Rigby C; Deep G; Jain A; Orlicky DJ; Agarwal C; Agarwal R
    Mol Carcinog; 2019 Jul; 58(7):1260-1271. PubMed ID: 30912211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/- mice.
    Paudel S; Raina K; Tiku VR; Maurya A; Orlicky DJ; You Z; Rigby CM; Deep G; Kant R; Raina B; Agarwal C; Agarwal R
    Carcinogenesis; 2022 Jun; 43(6):557-570. PubMed ID: 35184170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling.
    Li C; Chi S; He N; Zhang X; Guicherit O; Wagner R; Tyring S; Xie J
    Oncogene; 2004 Feb; 23(8):1608-17. PubMed ID: 14647422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
    Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
    Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature.
    Passarelli A; Galdo G; Aieta M; Fabrizio T; Villonio A; Conca R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
    Meani RE; Lim SW; Chang AL; Kelly JW
    Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
    PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
    Makinodan E; Marneros AG
    Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
    Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
    Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
    Tilley C; Deep G; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):688-97. PubMed ID: 26053157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.